For: | Ritchie SA, Chitou B, Zheng Q, Jayasinghe D, Jin W, Mochizuki A, Goodenowe DB. Pancreatic cancer serum biomarker PC-594: Diagnostic performance and comparison to CA19-9. World J Gastroenterol 2015; 21(21): 6604-6612 [PMID: 26074698 DOI: 10.3748/wjg.v21.i21.6604] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v21/i21/6604.htm |
Number | Citing Articles |
1 |
Peter McGranaghan, Ulrike Rennefahrt, Beate Kamlage, Regina Reszka, Philipp Schatz, Bianca Bethan, Julia Mayerle, Markus M. Lerch. Pancreatic Cancer. 2016; : 1 doi: 10.1007/978-1-4939-6631-8_61-1
|
2 |
Lucy Oldfield, Rohith Rao, Lawrence N. Barrera, Eithne Costello. Pancreatic Cancer. 2018; : 1241 doi: 10.1007/978-1-4939-7193-0_86
|
3 |
Yash Shah, Dushyant Singh Dahiya, Angad Tiwari, Harendra Kumar, Manesh Kumar Gangwani, Hassam Ali, Umar Hayat, Saqr Alsakarneh, Sahib Singh, Sheza Malik, Amir H. Sohail, Saurabh Chandan, Meer A. Ali, Sumant Inamdar. Advancements in Early Detection and Screening Strategies for Pancreatic Cancer: From Genetic Susceptibility to Novel Biomarkers. Journal of Clinical Medicine 2024; 13(16): 4706 doi: 10.3390/jcm13164706
|
4 |
Yu Shi, Feng Gao, Yue Li, Shengzhen Tao, Bing Yu, Zaiyi Liu, Yanqing Liu, Kevin J. Glaser, Richard L. Ehman, Qiyong Guo. Differentiation of benign and malignant solid pancreatic masses using magnetic resonance elastography with spin-echo echo planar imaging and three-dimensional inversion reconstruction: a prospective study. European Radiology 2018; 28(3): 936 doi: 10.1007/s00330-017-5062-y
|
5 |
Fawaz N. Al-Shaheri, Mohamed S.S. Alhamdani, Andrea S. Bauer, Nathalia Giese, Markus W. Büchler, Thilo Hackert, Jörg D. Hoheisel. Blood biomarkers for differential diagnosis and early detection of pancreatic cancer. Cancer Treatment Reviews 2021; 96: 102193 doi: 10.1016/j.ctrv.2021.102193
|
6 |
Navni Sharma, Vimal Arora. Strategies for drug targeting in pancreatic cancer. Pancreatology 2022; 22(7): 937 doi: 10.1016/j.pan.2022.08.001
|
7 |
Seoung Yoon Rho, Sang-Guk Lee, Minsu Park, Jinae Lee, Sung Hwan Lee, Ho Kyoung Hwang, Min Jung Lee, Young-Ki Paik, Woo Jung Lee, Chang Moo Kang. Developing a preoperative serum metabolome-based recurrence-predicting nomogram for patients with resected pancreatic ductal adenocarcinoma. Scientific Reports 2019; 9(1) doi: 10.1038/s41598-019-55016-x
|
8 |
Peter McGranaghan, Ulrike Rennefahrt, Beate Kamlage, Regina Reszka, Philipp Schatz, Bianca Bethan, Julia Mayerle, Markus M. Lerch. Pancreatic Cancer. 2018; : 1305 doi: 10.1007/978-1-4939-7193-0_61
|
9 |
Lumir Kunovsky, Pavla Tesarikova, Zdenek Kala, Radek Kroupa, Petr Kysela, Jiri Dolina, Jan Trna. The Use of Biomarkers in Early Diagnostics of Pancreatic Cancer. Canadian Journal of Gastroenterology and Hepatology 2018; 2018: 1 doi: 10.1155/2018/5389820
|
10 |
Kelsi Perttula, William M.B. Edmands, Hasmik Grigoryan, Xiaoming Cai, Anthony T. Iavarone, Marc J. Gunter, Alessio Naccarati, Silvia Polidoro, Alan Hubbard, Paolo Vineis, Stephen M. Rappaport. Evaluating Ultra-long-Chain Fatty Acids as Biomarkers of Colorectal Cancer Risk. Cancer Epidemiology, Biomarkers & Prevention 2016; 25(8): 1216 doi: 10.1158/1055-9965.EPI-16-0204
|
11 |
Ujjwal Mukund Mahajan, Qi Li, Beate Kamlage, Markus M. Lerch, Julia Mayerle. Translational Pancreatic Cancer Research. Molecular and Translational Medicine 2020; : 83 doi: 10.1007/978-3-030-49476-6_5
|
12 |
Hamid Tayebi Khosroshahi, Behzad Abedi, Sabalan Daneshvar, Yashar Sarbaz, Abolhassan Shakeri Bavil. Future of the Renal Biopsy: Time to Change the Conventional Modality Using Nanotechnology. International Journal of Biomedical Imaging 2017; 2017: 1 doi: 10.1155/2017/6141734
|
13 |
Natalia Calanzani, Paige E. Druce, Claudia Snudden, Kristi M. Milley, Rachel Boscott, Dawnya Behiyat, Smiji Saji, Javiera Martinez-Gutierrez, Jasmeen Oberoi, Garth Funston, Mike Messenger, Jon Emery, Fiona M. Walter. Identifying Novel Biomarkers Ready for Evaluation in Low-Prevalence Populations for the Early Detection of Upper Gastrointestinal Cancers: A Systematic Review. Advances in Therapy 2021; 38(2): 793 doi: 10.1007/s12325-020-01571-z
|
14 |
Tomas Koltai. Earlier Diagnosis of Pancreatic Cancer: Is It Possible?. Cancers 2023; 15(18): 4430 doi: 10.3390/cancers15184430
|
15 |
Hirofumi Akita, Shawn A. Ritchie, Ichiro Takemasa, Hidetoshi Eguchi, Elodie Pastural, Wei Jin, Yasuyo Yamazaki, Dayan B. Goodenowe, Hiroaki Nagano, Morito Monden, Masaki Mori, Yuichiro Doki. Serum Metabolite Profiling for the Detection of Pancreatic Cancer. Pancreas 2016; 45(10): 1418 doi: 10.1097/MPA.0000000000000680
|
16 |
Paul L. Wood. Endogenous Anti-Inflammatory Very-Long-Chain Dicarboxylic Acids: Potential Chemopreventive Lipids. Metabolites 2018; 8(4): 76 doi: 10.3390/metabo8040076
|
17 |
Julia Mayerle, Holger Kalthoff, Regina Reszka, Beate Kamlage, Erik Peter, Bodo Schniewind, Sandra González Maldonado, Christian Pilarsky, Claus-Dieter Heidecke, Philipp Schatz, Marius Distler, Jonas A Scheiber, Ujjwal M Mahajan, F Ulrich Weiss, Robert Grützmann, Markus M Lerch. Metabolic biomarker signature to differentiate pancreatic ductal adenocarcinoma from chronic pancreatitis. Gut 2018; 67(1): 128 doi: 10.1136/gutjnl-2016-312432
|
18 |
Khyati Y. Mehta, Hung-Jen Wu, Smrithi S. Menon, Yassi Fallah, Xiaogang Zhong, Nasser Rizk, Keith Unger, Mark Mapstone, Massimo S. Fiandaca, Howard J. Federoff, Amrita K. Cheema. Metabolomic biomarkers of pancreatic cancer: a meta-analysis study. Oncotarget 2017; 8(40): 68899 doi: 10.18632/oncotarget.20324
|
19 |
华锋 邱. Combined Detection of CA199, CA242 and CA50 in the Diagnosis for Pancreatic Cancer: A Meta Analysis. Advances in Clinical Medicine 2018; 8(04): 433 doi: 10.12677/ACM.2018.84073
|
20 |
Lucy Oldfield, Rohith Rao, Lawrence N Barrera, Eithne Costello. Pancreatic Cancer. 2017; : 1 doi: 10.1007/978-1-4939-6631-8_86-1
|